Glaucoma Medications Market
Glaucoma Medications Market Global Industry Assessment & Forecast
#
Pages:
142
2021
Nov - 2021
VMR-2021-0522
Segments Covered
By
Indication Open Angle Glaucoma, Closed Angle Glaucoma, Secondary Glaucoma, Congenital Glaucoma, Others
-
By
Drug Class Prostaglandin Analogs, Beta Blockers, Alpha Agonist, Carbonic Anhydrase Inhibitors, Others
Snapshot
 Forecast
Years:
|
2021 - 2028 |
 Historical
Years:
|
2016 - 2020 |
 Revenue
2021: |
7.51 Billion |
 Revenue 2028:
|
10.76 Billion |
 Revenue CAGR
(2021 - 2028): |
4.6 |
Fastest Growing Region (2022 -
2028)
|
North America |
Customization Offered
Cross-segment Market Size and
Analysis
for Mentioned Segments- Additional Company Profiles (Upto 5
With
No Cost)
- Additional Countries (Apart From
Mentioned Countries)
- Country/Region-specific Report
- Go To Market Strategy
- Region Specific Market Dynamics
- Region Level Market Share
- Import Export Analysis
- Production Analysis
- Others Request
Customization Speak To
Analyst
The report delivers an acute breakdown of the market based on various segments such as Indication, Drug Class, , and region. All the segments are studied considering historical and future trends across geographies. All the segments are analyzed based on trends, market size, and forecast, and the data is provided for the years 2016–2028. Several growth factors and opportunities impacting various segments have been incorporated in the report.
On the basis of Indication, the market is divided into Open Angle Glaucoma, Closed Angle Glaucoma, Secondary Glaucoma, Congenital Glaucoma, Others. Open Angle Glaucoma held the largest share in 2020 and is projected to grow at a noteworthy CAGR within the forecast period.
Based on Drug Class, the market is divided into Prostaglandin Analogs, Beta Blockers, Alpha Agonist, Carbonic Anhydrase Inhibitors, Others. Prostaglandin Analogs attributed to the highest market share and is expected to grow at a significant CAGR from 2021 to 2028.
Global Glaucoma Medications Market: Indication Segment Analysis
-
- Open Angle Glaucoma
- Closed Angle Glaucoma
- Secondary Glaucoma
- Congenital Glaucoma
- Others
Global Glaucoma Medications Market: Drug Class Segment Analysis
-
- Prostaglandin Analogs
- Beta Blockers
- Alpha Agonist
- Carbonic Anhydrase Inhibitors
- Others
FAQ
Frequently Asked Question
What is the global demand for Glaucoma Medications in terms of revenue?
-
The global Glaucoma Medications valued at 7.51 Billion in 2020 and is expected to reach 10.76 Billion in 2028 growing at a CAGR of 4.6%.
Which are the prominent players in the market?
-
The prominent players in the market are Laboratoires Thea, Actavis, APOTEX, GE Medical, Mylan, Taj Pharmaceuticals, Teva Pharmaceutical, Jamp Pharma, Greenstone, Mint Pharmaceuticals, SANDOZ, Bausch + Lomb, Fresenius, Sun Pharma, Laboratoire Riva, Pfizer, Novartis..
At what CAGR is the market projected to grow within the forecast period?
-
The market is project to grow at a CAGR of 4.6% between 2021 and 2028.
What are the driving factors fueling the growth of the market?
-
The driving factors of the Glaucoma Medications include
- The rising cases of glaucoma across the globe and new drug developments are expected to fuel the growth of the market during the forecast period.
- The technological advancement in treatment of glaucoma, and various pharmaceutical and biotechnological companies are investing in new product development for glaucoma is a factor driving the market.
Which region accounted for the largest share in the market?
-
North America was the leading regional segment of the Glaucoma Medications in 2020.
